Systemic administration of 3-

Share "Systemic administration of 3-"

N/A

Protected

Ano acadêmico: 2023

Info

Descarregar agora

Protected

Academic year: 2023

Share "Systemic administration of 3-"

Copied!

Carregando.... (Ver texto completo agora)

Descarregar agora ( 2 páginas )

Texto

Referências

Descarregar agora ( PDF - 2 páginas - 135.24 KB )

Documentos relacionados

Antagonistic inflammatory phenotypes dictate tumor fate and response to immune checkpoint blockade

Early control of Ptgs / tumors was still noticeable in Rag1 / mice lacking adaptive immunity (Figure 1E), arguing for direct NK cell cytotoxic activity against Ptgs / tumor

Documentos relacionados

. Haploinsufficiency of the SHANK3 gene, which encodes a master scaffolding protein in the postsynaptic density of glutamatergic synapses

A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics

View of Investigation of the Effects of Antimicrobials to Control Campylobacter Jejuni in Chicken Carcass

Proposta de modelo de planejamento estratégico para Associação Rurart

2'-Hydroxyflavanone activity in vitro and in vivo against wild-type and antimony-resistant Leishmania amazonensis

Antitumour properties of the leaf essential oil of Xylopia frutescens Aubl. (Annonaceae)

Bergenin Reduces Experimental Painful Diabetic Neuropathy by Restoring Redox and Immune Homeostasis in the Nervous System

Betulinic Acid Derivative BA5, Attenuates Inflammation and Fibrosis in Experimental Chronic Chagas Disease Cardiomyopathy by Inducing IL-10 and M2 Polarization